DVA
DaVita Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+13/100
Last price
175.75
▼ 2.97 (1.66%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
178.09
Prev close
178.72
Day high
181.82
Day low
178.88
Volume
374.36K
Market cap
$11.51B
P/E (TTM)
15.10
52W range
101.00 – 247.49
Day trading desk
Gap from prior close
-0.35%
Prior close 178.72
VWAP
180.56
-2.66% from price
Relative volume
0.84×
Normal
Session range
3.45%
175.75 – 181.82
Position in range
0%
Near session low
ATR (14D)
4.98
2.83% of price
Prior day high
179.66
PDH
Prior day low
177.43
PDL
Bid / ask spread
—
Quote not published
Session volume
651.92K
Avg 776.03K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.97%
+1.0%
1M
-1.95%
-3.1%
3M
-21.81%
-26.3%
6M
+20.51%
+2.3%
YTD
+58.79%
+44.5%
1Y
+37.54%
+21.1%
3Y
+90.84%
+8.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DVA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-1.56M
Net selling
Buy transactions
18
15.05K shares
Sell transactions
8
1.58M shares
Net transactions
+26
Buys less sells
Sell : buy shares
104.8 : 1
Heavily one-sided
Insider-held shares
29.93M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | DESOER BARBARA J Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | YALE PHYLLIS R Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | HOLLAR JASON M Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | MOORE GREGORY J Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | PULLIN DENNIS W Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | ARWAY PAMELA M. Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | SCHECHTER ADAM H Director |
STOCK | 278 | $0 | Direct |
| Aug 14, 26 | SCHOPPERT WENDY LEE Director |
STOCK | 278 | $0 | Direct |
| Jul 31, 26 | BERKSHIRE HATHAWAY, INC. Beneficial Owner of more than 10% of a Class of Security |
SELL | 182.98K | $36.51M | Indirect |
| Jun 16, 26 | RODRIGUEZ JAVIER J Chief Executive Officer |
SELL | 69.41K | $14.53M | Direct |
| Jun 15, 26 | WATERS KATHLEEN ALYCE Officer |
SELL | 15.40K | $3.21M | Direct |
| May 26, 26 | YALE PHYLLIS R Director |
STOCK | 5.04K | $0 | Direct |
| May 15, 26 | HEARTY JAMES O Officer |
SELL | 15.00K | $2.91M | Direct |
| May 15, 26 | DESOER BARBARA J Director |
STOCK | 250 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ACKERMAN JOEL |
Chief Financial Officer | 132.43K | Sale |
ARWAY PAMELA M. |
Director | 27.22K | Stock Award(Grant) |
BERG CHARLES G |
Director | 27.03K | Stock Award(Grant) |
BERKSHIRE HATHAWAY, INC. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
BERRY CHRISTOPHER MICHAEL |
Officer | 19.64K | Stock Award(Grant) |
DESOER BARBARA J |
Director | 14.30K | Stock Award(Grant) |
HEARTY JAMES O |
Officer | 22.39K | Sale |
MAUGHAN DAVID PAUL |
Officer | 94.11K | Sale |
RODRIGUEZ JAVIER J |
Chief Executive Officer | 840.41K | Sale |
WATERS KATHLEEN ALYCE |
Officer | 109.19K | Sale |
Fundamentals
Market cap$11.51B
Enterprise value$26.07B
Revenue (TTM)$14.01B
Gross profit$4.53B
EBITDA$2.83B
Net income$822.48M
EPS (TTM)$11.95
Free cash flow$1.04B
Total cash$688.88M
Total debt$13.41B
Book value / share$-11.96
Shares outstanding63.80M
Float33.93M
Short % of float13.25%
Dividend yield0.00%
Beta (5Y)0.80
Valuation & profitability ratios
Trailing P/E15.10
Forward P/E10.52
PEG ratio0.44
Price / sales—
Price / book—
EV / revenue1.86
EV / EBITDA9.23
Gross margin32.36%
Operating margin16.06%
Profit margin6.05%
Return on equity88.48%
Return on assets7.51%
Debt / equity1,241.99
Current ratio1.47
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $13.64B | $12.82B | $12.14B | $11.61B | +6.5% |
| Operating revenue | $13.01B | $12.26B | $11.57B | $11.18B | +6.1% |
| Cost of revenue | $9.24B | $8.60B | $8.32B | $8.21B | +7.5% |
| Gross profit | $4.40B | $4.22B | $3.82B | $3.40B | +4.3% |
| Selling, general & admin | $1.67B | $1.54B | $1.47B | $1.36B | +8.8% |
| Total operating expense | $2.39B | $2.26B | $2.22B | $2.09B | +5.6% |
| Operating income | $2.01B | $1.95B | $1.60B | $1.31B | +2.9% |
| Net interest income | -$579.93M | -$470.47M | -$398.55M | -$357.02M | -23.3% |
| Pre-tax income | $1.35B | $1.53B | $1.18B | $966.28M | -12.0% |
| Tax provision | $293.11M | $279.66M | $220.12M | $198.09M | +4.8% |
| Net income | $746.80M | $936.34M | $691.53M | $560.40M | -20.2% |
| Net income to common | $746.80M | $936.34M | $691.53M | $560.40M | -20.2% |
| Basic EPS | 10.06 | 11.02 | 7.62 | 6.03 | -8.7% |
| Diluted EPS | 9.84 | 10.73 | 7.42 | 5.85 | -8.3% |
| EBIT | $1.93B | $2.00B | $1.58B | $1.32B | -3.7% |
| EBITDA | $2.64B | $2.72B | $2.32B | $2.06B | -3.0% |
| Basic shares | 74.23M | 84.99M | 90.79M | 92.99M | -12.7% |
| Diluted shares | 75.89M | 87.27M | 93.18M | 95.83M | -13.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $676.44M | $794.93M | $380.06M | $244.09M | -14.9% |
| Cash & short-term investments | $700.74M | $846.00M | $391.67M | $321.78M | -17.2% |
| Accounts receivable | $2.41B | $2.15B | $1.99B | $2.13B | +12.5% |
| Inventory | $160.63M | $134.56M | $143.10M | $109.12M | +19.4% |
| Total current assets | $4.06B | $3.75B | $3.14B | $3.16B | +8.3% |
| Property, plant & equipment | $5.21B | $5.33B | $5.57B | $5.92B | -2.3% |
| Goodwill & intangibles | $7.77B | $7.57B | $7.32B | $7.26B | +2.6% |
| Total assets | $17.48B | $17.29B | $16.89B | $16.93B | +1.1% |
| Total current liabilities | $3.14B | $2.97B | $2.64B | $2.62B | +5.7% |
| Current debt | $109.20M | $270.87M | $123.30M | $231.40M | -59.7% |
| Long-term debt | $10.16B | $9.18B | $8.27B | $8.69B | +10.8% |
| Total debt | $12.87B | $12.07B | $11.12B | $11.82B | +6.7% |
| Total liabilities | $16.32B | $15.19B | $14.15B | $14.70B | +7.4% |
| Retained earnings | -$328.43M | $1.53B | $598.29M | $174.49M | -121.4% |
| Shareholder equity | -$651.08M | $121.12M | $1.06B | $712.33M | -637.5% |
| Working capital | $916.37M | $772.66M | $495.69M | $535.54M | +18.6% |
| Net tangible assets | -$8.42B | -$7.45B | -$6.26B | -$6.55B | -13.0% |
| Shares issued | 68.55M | 90.37M | 88.82M | 90.41M | -24.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.08B | $1.25B | $956.98M | $781.64M | -13.8% |
| Depreciation & amortisation | $715.35M | $723.86M | $745.44M | $732.60M | -1.2% |
| Stock-based compensation | $139.95M | $102.79M | $112.38M | $95.43M | +36.2% |
| Change in working capital | -$263.24M | -$29.82M | $194.53M | $101.00K | -782.7% |
| Operating cash flow | $1.89B | $2.02B | $2.06B | $1.56B | -6.7% |
| Capital expenditure | -$575.86M | -$555.44M | -$567.99M | -$603.43M | -3.7% |
| Investing cash flow | -$654.95M | -$771.43M | -$771.80M | -$630.35M | +15.1% |
| Share buybacks | -$1.79B | -$1.39B | -$272.22M | -$802.23M | -29.4% |
| Financing cash flow | -$1.37B | -$816.94M | -$1.17B | -$1.12B | -68.3% |
| Free cash flow | $1.31B | $1.47B | $1.49B | $961.14M | -10.6% |
| End cash position | $757.75M | $879.83M | $464.63M | $338.99M | -13.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | +4.1% |
| Operating revenue | $3.37B | $3.27B | $3.40B | $3.30B | $3.21B | +2.9% |
| Cost of revenue | $2.39B | $2.34B | $2.41B | $2.33B | $2.26B | +2.1% |
| Gross profit | $1.16B | $1.07B | $1.21B | $1.09B | $1.12B | +8.3% |
| Selling, general & admin | $423.46M | $421.91M | $472.36M | $414.37M | $412.81M | +0.4% |
| Total operating expense | $591.27M | $599.74M | $659.07M | $591.86M | $587.51M | -1.4% |
| Operating income | $570.82M | $473.55M | $551.21M | $495.61M | $530.48M | +20.5% |
| Net interest income | -$150.26M | -$145.13M | -$148.25M | -$150.56M | -$146.06M | -3.5% |
| Pre-tax income | $435.01M | $341.23M | $382.76M | $308.80M | $368.93M | +27.5% |
| Tax provision | $91.79M | $66.20M | $76.73M | $68.55M | $93.71M | +38.7% |
| Net income | $265.40M | $197.53M | $234.22M | $150.33M | $199.34M | +34.4% |
| Net income to common | $265.40M | $197.53M | $234.22M | $150.33M | $199.34M | +34.4% |
| Basic EPS | 4.10 | 2.93 | 3.36 | 2.09 | 2.62 | +39.9% |
| Diluted EPS | 4.02 | 2.87 | 3.29 | 2.04 | 2.58 | +40.1% |
| EBIT | $585.27M | $486.37M | $531.01M | $459.36M | $514.99M | +20.3% |
| EBITDA | $753.07M | $664.19M | $717.71M | $636.85M | $689.69M | +13.4% |
| Basic shares | 64.78M | 67.39M | 69.65M | 72.08M | 75.94M | -3.9% |
| Diluted shares | 66.09M | 68.88M | 71.26M | 73.77M | 77.36M | -4.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $668.96M | $644.24M | $676.44M | $705.96M | $708.42M | +3.8% |
| Cash & short-term investments | $688.88M | $666.55M | $700.74M | $736.48M | $739.43M | +3.4% |
| Accounts receivable | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | +0.3% |
| Inventory | $151.53M | $141.61M | $160.63M | $139.09M | $146.29M | +7.0% |
| Total current assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | +3.1% |
| Property, plant & equipment | $5.18B | $5.15B | $5.21B | $5.18B | $5.19B | +0.5% |
| Goodwill & intangibles | $7.82B | $7.81B | $7.77B | $7.76B | $7.68B | +0.1% |
| Total assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | +1.2% |
| Total current liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | -0.4% |
| Current debt | $117.18M | $112.65M | $109.20M | $62.92M | $182.44M | +4.0% |
| Long-term debt | $10.66B | $10.51B | $10.16B | $10.18B | $10.08B | +1.4% |
| Total debt | $13.41B | $13.22B | $12.87B | $12.78B | $12.82B | +1.4% |
| Total liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | +1.1% |
| Retained earnings | $81.23M | -$179.24M | -$328.43M | $2.05B | $1.90B | +145.3% |
| Shareholder equity | -$765.10M | -$755.50M | -$651.08M | -$571.87M | -$369.63M | -1.3% |
| Working capital | $1.33B | $1.20B | $916.37M | $1.09B | $1.15B | +11.6% |
| Net tangible assets | -$8.58B | -$8.57B | -$8.42B | -$8.34B | -$8.05B | -0.2% |
| Shares issued | 63.95M | 69.19M | 68.55M | 90.81M | 90.78M | -7.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $343.22M | $275.04M | $331.03M | $240.25M | $275.22M | +24.8% |
| Depreciation & amortisation | $167.81M | $177.83M | $186.70M | $177.49M | $174.70M | -5.6% |
| Stock-based compensation | $26.03M | $28.16M | $38.39M | $38.99M | $32.81M | -7.6% |
| Change in working capital | -$58.11M | -$221.67M | -$54.83M | $253.34M | -$171.60M | +73.8% |
| Operating cash flow | $490.07M | $320.83M | $540.73M | $841.53M | $324.24M | +52.7% |
| Capital expenditure | -$169.82M | -$102.02M | -$145.43M | -$166.09M | -$121.09M | -66.5% |
| Investing cash flow | -$194.25M | -$139.09M | -$163.13M | -$262.52M | -$67.17M | -39.7% |
| Share buybacks | -$364.35M | -$396.31M | -$328.83M | -$470.08M | -$452.25M | +8.1% |
| Financing cash flow | -$270.19M | -$213.34M | -$414.52M | -$582.16M | $4.45M | -26.6% |
| Free cash flow | $320.25M | $218.81M | $395.30M | $675.44M | $203.15M | +46.4% |
| End cash position | $751.86M | $726.40M | $757.75M | $795.41M | $796.96M | +3.5% |
Options analytics
Put / call volume
0.47
Call-heavy session
Put / call open interest
0.16
Positioning, not flow
Max pain
180.00
-0.2% from spot
ATM implied vol
40.3%
Nearest strike to spot
Skew (10% OTM)
+4.9%
Puts bid over calls
Call volume
261
Contracts, this expiry
Put volume
122
Contracts, this expiry
Heaviest call OI
195.00
3.47K contracts
Heaviest put OI
170.00
744 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.88 | 4.02 | +3.6% |
| Mar 2026 | 2.33 | 2.87 | +23.2% |
| Dec 2025 | 3.19 | 3.40 | +6.5% |
| Sep 2025 | 3.17 | 2.51 | -20.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 3.57 | 7 | $3.52B | +2.8% |
| Next quarter | 4.40 | 7 | $3.61B | -0.2% |
| Current year | 14.82 | 7 | $14.16B | +3.8% |
| Next year | 17.14 | 8 | $14.64B | +3.4% |
Analyst targets & ownership
Mean target$219.86
High target$270.00
Low target$165.00
Implied upside25.10%
Analyst count7
ConsensusBUY
Strong buy / Buy0 / 3
Hold4
Sell / Strong sell0 / 1
Held by insiders46.91%
Held by institutions48.26%
Institutions holding859
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
177.86
-1.19% from price
SMA 20
181.58
-0.65% from price
SMA 50
187.21
-3.64% from price
SMA 100
200.31
-12.26% from price
SMA 200
170.69
+5.69% from price
EMA 12
179.20
-1.93% from price
EMA 26
181.75
-3.30% from price
EMA 50
186.90
-5.96% from price
RSI (14)
47.5
Neutral
MACD (12,26,9)
-2.55
Hist 0.36
ATR (14)
4.98
2.76% of price
Realised vol 30D
30.8%
Annualised
Bollinger upper
191.73
20, 2σ
Bollinger lower
171.43
20, 2σ
50 / 200 cross
Golden
187.21 vs 170.69
Trend bias
Above 200
+5.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.01
Less volatile than market
Correlation to SPY
-0.00
Largely independent
Realised vol 30D
30.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.9%
Peak to trough
Max drawdown 5Y
-47.0%
Peak to trough
ATR 14
4.98
2.76% of price
Beta (reported)
0.80
5Y monthly, from filing
Short interest
Shares short
4.30M
Prior 4.00M
Change vs prior
+7.4%
Shorts adding
% of float
13.25%
Elevated
% of shares out
6.74%
Against total outstanding
Days to cover
7.2
Crowded exit
Float
33.93M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | TD Cowen | UPGRADE | Hold | Buy |
| Aug 7, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 5, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 14, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 10, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 11, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| May 8, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| May 8, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 7, 26 | UBS | MAINTAINED | Buy | Buy |
| May 6, 26 | Deutsche Bank | UPGRADE | Hold | Buy |
| Feb 4, 26 | UBS | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateSep 9, 2013
SEC filings
Periodic Financial Reports
10-Q · 2026-08-04
Annual report of employee stock purchase
11-K · 2026-06-17
Corporate Changes & Voting Matters
8-K · 2026-06-08
Periodic Financial Reports
10-Q · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-22
Periodic Financial Reports
10-K · 2026-02-11
Corporate Changes & Voting Matters
8-K · 2026-02-02
Corporate Changes & Voting Matters
8-K · 2025-11-25
Headlines
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
Zacks · 4d ago
3 Cash-Producing Stocks with Open Questions
StockStory · 7d ago
DaVita (DVA) Stock May Be Undervalued On Its Earnings Power
Simply Wall St. · 7d ago
This Warren Buffett Stock Is Up 58%. History Says This Is What Happens Next.
Motley Fool · 8d ago
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks · 12d ago
1 Profitable Stock with Competitive Advantages and 2 That Underwhelm
StockStory · 13d ago
Is DaVita Stock Underperforming the S&P 500?
Barchart · 14d ago
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
PR Newswire · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.